English

Beyond just "flattening the curve": Optimal control of epidemics with purely non-pharmaceutical interventions

Populations and Evolution 2020-08-19 v3 Dynamical Systems Optimization and Control Physics and Society

Abstract

When effective medical treatment and vaccination are not available, non-pharmaceutical interventions such as social distancing, home quarantine and far-reaching shutdown of public life are the only available strategies to prevent the spread of epidemics. Based on an extended SEIR (susceptible-exposed-infectious-recovered) model and continuous-time optimal control theory, we compute the optimal non-pharmaceutical intervention strategy for the case that a vaccine is never found and complete containment (eradication of the epidemic) is impossible. In this case, the optimal control must meet competing requirements: First, the minimization of disease-related deaths, and, second, the establishment of a sufficient degree of natural immunity at the end of the measures, in order to exclude a second wave. Moreover, the socio-economic costs of the intervention shall be kept at a minimum. The numerically computed optimal control strategy is a single-intervention scenario that goes beyond heuristically motivated interventions and simple "flattening of the curve." Careful analysis of the computed control strategy reveals, however, that the obtained solution is in fact a tightrope walk close to the stability boundary of the system, where socio-economic costs and the risk of a new outbreak must be constantly balanced against one another. The model system is calibrated to reproduce the initial exponential growth phase of the COVID-19 pandemic in Germany.

Keywords

Cite

@article{arxiv.2004.09471,
  title  = {Beyond just "flattening the curve": Optimal control of epidemics with purely non-pharmaceutical interventions},
  author = {Markus Kantner and Thomas Koprucki},
  journal= {arXiv preprint arXiv:2004.09471},
  year   = {2020}
}

Comments

Keywords: Mathematical epidemiology, optimal control, non-pharmaceutical interventions, effective reproduction number, dynamical systems, COVID-19, SARS-CoV2